NEFL and myeloid sarcoma: The plasma NfL levels in both the acute and remission stages of MS were higher than those in healthy individuals, implying a significant increase in NfL during the acute stage of the disease, further demonstrating that NfL, as a marker of neuronal axonal injury, is always associated with inflammatory activity in MS, and has important significance in monitoring disease activity.